Viatris (VTRS) Non-Current Debt (2019 - 2026)
Viatris (VTRS) recorded quarterly Non-Current Debt of $12.4 billion in Q1 2026, down 0.54% quarter-over-quarter from $12.5 billion in Q4 2025, and down 12.44% on a YoY basis from $14.2 billion in Q1 2025.
Viatris (VTRS) Non-Current Debt (2019 - 2026) Analysis & Trends
Viatris' Non-Current Debt history runs 8 years deep, the most recent figure standing at $12.4 billion for Q1 2026.
- In Q1 2026, Non-Current Debt fell 12.44% year-over-year to $12.4 billion; the TTM figure through Mar 2026 stood at $12.4 billion (down 12.44% YoY), while the FY2025 annual figure was $12.5 billion, down 11.1% from the prior year.
- Non-Current Debt was $12.4 billion for Q1 2026 at Viatris, down from $12.5 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $19.2 billion in Q2 2022 to a low of $12.4 billion in Q1 2026.
- Historically, Non-Current Debt has averaged $15.7 billion across 5 years, with a median of $16.1 billion in 2024.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt dropped 3.69% in 2023, then fell 16.24% in 2024.
- A 5-year view of Non-Current Debt shows it stood at $18.0 billion in 2022, then fell by 10.14% to $16.2 billion in 2023, then dropped by 13.28% to $14.0 billion in 2024, then declined by 11.1% to $12.5 billion in 2025, then decreased by 0.54% to $12.4 billion in 2026.
- The last three Non-Current Debt figures came in at $12.4 billion (Q1 2026), $12.5 billion (Q4 2025), and $12.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Viatris | - | - | 1.16 Bn | 12.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.41 Bn |
| Mar 31, 2026 | 12.41 Bn |
| Dec 31, 2025 | 12.48 Bn |
| Dec 31, 2025 | 12.48 Bn |
| Sep 30, 2025 | 12.49 Bn |
| Sep 30, 2025 | 12.49 Bn |
| Jun 30, 2025 | 12.79 Bn |
| Jun 30, 2025 | 12.79 Bn |
| Mar 31, 2025 | 14.18 Bn |
| Mar 31, 2025 | 14.18 Bn |
| Dec 31, 2024 | 14.04 Bn |
| Dec 31, 2024 | 14.04 Bn |
| Sep 30, 2024 | 14.30 Bn |
| Sep 30, 2024 | 14.30 Bn |
| Jun 30, 2024 | 14.73 Bn |
| Jun 30, 2024 | 14.73 Bn |
| Mar 31, 2024 | 16.07 Bn |
| Mar 31, 2024 | 16.07 Bn |
| Dec 31, 2023 | 16.19 Bn |
| Dec 31, 2023 | 16.19 Bn |